Filing Details
- Accession Number:
- 0000899243-20-031671
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-19 17:16:33
- Reporting Period:
- 2020-11-17
- Accepted Time:
- 2020-11-19 17:16:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1490978 | Schrodinger Inc. | SDGR | Pharmaceutical Preparations (2834) | 954284541 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1797727 | Cony D'cruz | C/O Schrodinger, Inc., 120 West 45Th Street, 17Th Floor New York NY 10036 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-17 | 4,375 | $4.34 | 4,375 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-17 | 4,375 | $60.69 | 0 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 2,000 | $60.69 | 171,082 | No | 4 | S | Indirect | By Cony and Pearl D'Cruz Revocable Trust dated August 20, 2019, and any amendments thereto |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By Cony and Pearl D'Cruz Revocable Trust dated August 20, 2019, and any amendments thereto |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2020-11-17 | 4,375 | $0.00 | 4,375 | $4.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
22,379 | 2028-11-29 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2020.
- This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.